TrialFrontiers in immunology2021

CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab.

Xiao L Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.